Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Basic treatment: sulperazone + ursodeoxycholic acid + compound glycyrrhizin + methylprednisolone + vitamin AD , D , E , K + imipenem or meropenem
(D00206)
[4] Imipenem,
Meropenem,
Methylprednisolone,
Ursodeoxycholic acid
[7] Imipenem (D00206),
Methylprednisolone ,
Ursodiol ,
Methylprednisolone acetate ,
Meropenem ,
Imipenem ,
Meropenem 💬
[2] NR1H4,
NR3C1 💬
[2] Bile secretion, Neuroactive ligand-receptor interaction 💬[1] 296 💬
2Imipenem
(D00206)
[1] Imipenem[2] Imipenem (D00206),
Imipenem 💬
--[3] 60, 296, 299 💬
3Imipenem + Cilastatin
(D00206)
[2] Cilastatin,
Imipenem
[4] Imipenem (D00206),
Cilastatin sodium ,
Imipenem ,
Cilastatin 💬
--[1] 299 💬
4Imipenem / cilastatine
(D00206)
[2] Cilastatin,
Imipenem
[4] Imipenem (D00206),
Cilastatin sodium ,
Imipenem ,
Cilastatin 💬
--[1] 60 💬
5Imipenem-cilastatine
(D00206)
[2] Cilastatin,
Imipenem
[4] Imipenem (D00206),
Cilastatin sodium ,
Imipenem ,
Cilastatin 💬
--[1] 60 💬
6Imipenem/Cilastatin/Relebactam
(D00206)
[3] Cilastatin,
Imipenem,
Relebactam
[5] Imipenem (D00206),
Cilastatin sodium ,
Imipenem ,
Cilastatin ,
Relebactam 💬
--[1] 299 💬